From the Medical Scientist Training Program, Northwestern University Feinberg School of Medicine, Chicago, IL.
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Cancer J. 2024;30(4):232-237. doi: 10.1097/PPO.0000000000000726.
The optimal management of T3N0 rectal cancer is an area of active debate that has withstood multiple decades of research. In this comprehensive review, we delve into the many nuances that come with treating T3N0 rectal cancer, particularly examining the role and evolution of radiation therapy. We review both the historical paradigms and latest advances in treatment and highlight the significance of precise preoperative staging. As the field continues to evolve, this review highlights a shift toward more tailored treatments, considering both patient goals and the desire for optimal oncologic outcomes. In the current era, clinical decision-making for T3N0 rectal cancer requires a patient-centric approach that balances effective therapy while minimizing undue side effects.
T3N0 期直肠癌的最佳治疗方法是一个活跃的争论领域,已经经受了几十年的研究。在这篇全面的综述中,我们深入探讨了治疗 T3N0 期直肠癌所涉及的诸多细微差别,特别研究了放射治疗的作用和演变。我们回顾了治疗的历史范例和最新进展,并强调了精确术前分期的重要性。随着该领域的不断发展,本综述强调了向更具针对性的治疗方法转变的趋势,既要考虑患者的目标,也要考虑获得最佳肿瘤学结果的愿望。在当前时代,T3N0 期直肠癌的临床决策需要采取以患者为中心的方法,在平衡有效治疗的同时最大限度地减少不必要的副作用。